Information about Lariam (Mefloquine)
Lariam is an antimalarial medication that contains mefloquine as its active ingredient. It is primarily used for the prevention and treatment of malaria, particularly in areas where malaria parasites are resistant to other medications.
Product Highlights
- Recommended for travelers to areas with high malaria transmission.
- Effective against acute malaria caused by Plasmodium falciparum and Plasmodium vivax.
Key Ingredient
Key Benefits
- Once-weekly dosing for prevention makes it easier for travelers.
- Provides effective protection and treatment against malaria.
- Generally well-received, with a favorable safety profile for most patients.
Direction of Use
- Start taking Lariam at least one week before travel to a malaria-endemic area, continuing for four weeks after leaving the area.
- For acute malaria, the dosage will vary based on the patient's condition and the severity of the infection; follow healthcare provider instructions closely.
Safety Concerns
- Can cause side effects such as dizziness, anxiety, vivid dreams, and other psychiatric symptoms.
- May interact with other medications, so inform your healthcare provider of all current medications.
- Use during pregnancy should be considered only if the benefits outweigh the risks.
Avoid Lariam (Mefloquine) If
- You have a known hypersensitivity to mefloquine or any of its components.
- You have a history of severe neuropsychiatric disorders, including depression or anxiety.
- You are currently taking other medications that may interact adversely with mefloquine.
